A urine drug screen that reports both amphetamine (AMP) and methamphetamine (mAMP) confuses a lot of people, including some employers who read the printout for the first time. The two analytes sit next to each other on almost every multi-panel cup because they are chemically related, and a single use of methamphetamine can trigger a positive result on both lines. That overlap is not a lab error. It is basic pharmacology, and understanding it is the difference between reading a screen correctly and sending someone home over a result that a Medical Review Officer would have cleared in five minutes.
What AMP and mAMP panels actually detect
Most drug test cups sold for workplace, probation, or treatment use include separate strips for amphetamine and methamphetamine, sometimes labeled AMP and mAMP, sometimes labeled AMP/MAMP or MET. Each strip is an immunoassay tuned to a class of related stimulant compounds rather than one single molecule. The methamphetamine strip is built to catch methamphetamine itself, and the amphetamine strip catches amphetamine along with several amphetamine-type stimulants that share a similar structure, including MDMA and MDA on panels that carry that analyte separately.
Under the federal cutoff schedule that most workplace and DOT programs follow, the initial immunoassay screen for amphetamine or methamphetamine is set at 500 ng/mL, and a confirmatory test by gas chromatography-mass spectrometry (GC/MS) must independently verify amphetamine at 250 ng/mL and methamphetamine at 250 ng/mL. Those are the numbers laid out in the federal drug testing regulations that certified laboratories must follow.
| Analyte | Initial immunoassay cutoff | Confirmatory GC/MS cutoff |
|---|---|---|
| Amphetamine/Methamphetamine (combined screen) | 500 ng/mL | N/A, triggers confirmation |
| Amphetamine (confirmatory) | N/A | 250 ng/mL |
| Methamphetamine (confirmatory) | N/A | 250 ng/mL |
These are the cutoffs set out in 49 CFR 40.85, which governs urine drug test cutoff concentrations for federally regulated testing. A lot of commercial cups use the same numbers even outside a DOT context because the reagents and the regulatory history line up. If you are shopping panels for a workplace program, a 12 panel drug test is the most common configuration that carries both AMP and mAMP as separate results on one cup.
Why methamphetamine use makes amphetamine show up too
Methamphetamine is not fully eliminated from the body unchanged. A portion of it is metabolized into amphetamine, so a urine sample from someone who used methamphetamine will typically contain both compounds, with methamphetamine present at a higher concentration than the amphetamine it converted to. That is why a confirmed methamphetamine positive so often carries a confirmed amphetamine positive on the same report. It is expected chemistry, not a duplicate finding or a second drug.
The reverse is not true. Someone who has only taken a prescription amphetamine product does not produce methamphetamine as a byproduct, because amphetamine does not metabolize upward into methamphetamine. So a lab report that shows methamphetamine present, confirmed by GC/MS, at a real concentration, is not something a legitimate Adderall or Vyvanse prescription can explain on its own. That distinction is exactly why the MRO review step exists, and it is why isolated amphetamine positives get handled very differently from confirmed methamphetamine positives.
Prescription stimulants vs illicit methamphetamine
Amphetamine and methamphetamine are both Schedule II controlled substances under the Controlled Substances Act, which means both have an accepted medical use alongside a high potential for abuse. The difference an employer or MRO cares about is source and legitimacy, not the schedule itself.
| Prescription stimulants (Adderall, Vyvanse, and similar) | Illicit methamphetamine | |
|---|---|---|
| Active compound | Dextroamphetamine and/or amphetamine mixed salts; Vyvanse is lisdexamfetamine, a prodrug that converts to dextroamphetamine | d-methamphetamine, which metabolizes in part to d-amphetamine |
| What confirms on GC/MS | Amphetamine only | Methamphetamine, usually with amphetamine present as well |
| Legitimate explanation available | Valid prescription, verified by MRO with the prescriber or pharmacy | None for a genuine d-methamphetamine confirmation; the only recognized exception involves the l-isomer found in an OTC nasal inhaler |
Adderall, Adderall XR, and similar ADHD medications are FDA-approved formulations of amphetamine and dextroamphetamine salts, and the FDA-approved prescribing label for Adderall XR confirms the active ingredients and indicated use for attention deficit hyperactivity disorder. A person taking one of these medications as prescribed will confirm positive for amphetamine and nothing else. We cover the prescription side of this in more depth in our piece on Adderall, amphetamine, and how the MRO handles it.
The d- and l-isomer problem
Amphetamine and methamphetamine each exist as two mirror-image forms, called the d-isomer and the l-isomer. The d-isomer is the form found in prescription stimulants and in street methamphetamine, and it is the form with real central nervous system activity. The l-isomer barely crosses into the brain and has almost no stimulant effect, but a standard immunoassay screen and even a basic GC/MS confirmation do not automatically tell the two apart unless the laboratory runs a specific stereoisomer test.
The practical case where this matters is a decongestant nasal inhaler that contains levmetamfetamine, the l-isomer of methamphetamine. It is sold over the counter for nasal congestion, it is legal, and it can produce a confirmed methamphetamine positive on a standard test because standard GC/MS confirmation targets the molecule, not the isomer. This is exactly the scenario the isomer test exists to resolve. Federal MRO procedure allows the reviewing physician to request that a certified laboratory perform d,l-stereoisomer testing on amphetamine and methamphetamine results specifically to sort out cases like this, as described in 49 CFR 40.141, which governs how the MRO obtains information for a verification decision. If the stereoisomer test comes back showing the sample is predominantly or entirely l-methamphetamine, the MRO has the basis to verify the result negative rather than positive, because that pattern is consistent with the inhaler and not with methamphetamine use or a legitimate prescription.
This is a narrow exception. It applies to a specific over-the-counter product with a specific isomer profile, not to any claim of accidental exposure. An employee who says they used an inhaler but whose sample confirms as the d-isomer, or as a mix consistent with actual methamphetamine use, does not get the benefit of this explanation.
How the MRO reviews a non-negative amphetamine or methamphetamine result
A confirmed positive from the lab is not a final verdict. It goes to a Medical Review Officer, a licensed physician trained in reviewing drug test results, before it becomes a reportable positive. For an amphetamine confirmation, the MRO's first move is to ask the employee whether they hold a valid prescription for a stimulant medication and to verify that prescription directly with the pharmacy or prescriber rather than take the employee's word for it. If the prescription checks out and the medication accounts for the result, the MRO records the result as negative for reporting purposes even though the lab confirmed a positive.
For a confirmed methamphetamine result, the review is tighter, because there is no prescription medication that legitimately produces confirmed d-methamphetamine in urine. The MRO's options narrow to genuine methamphetamine use, or, in the specific inhaler scenario above, a request for stereoisomer testing to check whether the result is explainable by the l-isomer product. Absent that fact pattern, a confirmed methamphetamine positive stands. This is one of the more technical calls an MRO makes, and it is a good example of why that role exists as a clinical checkpoint rather than a formality. We go through the full non-negative review process, including timelines and what employers should expect to hear back, in our article on how the Medical Review Officer process works.
What this means for choosing a panel
If your program needs to catch both prescription stimulant misuse and illicit methamphetamine use, you want a panel that reports AMP and mAMP as separate lines rather than a single combined stimulant result, because separate lines are what let an MRO see the pattern described above and make the right call. Most standard multi-panel cups built for pre-employment, random, and DOT-adjacent workplace programs already do this. Our workplace drug testing solutions for employers page has the panel configurations most companies use for this, along with the paperwork and collection supplies to run the program correctly from the start. Federal guidance for how these programs should be structured, including certified laboratory requirements, is maintained by the Substance Abuse and Mental Health Services Administration workplace program.
Frequently asked questions
Does taking Adderall cause a positive methamphetamine result?
No. Adderall and similar prescription stimulants are amphetamine and dextroamphetamine salts, not methamphetamine. A person taking Adderall as prescribed confirms positive for amphetamine only. A separate confirmed methamphetamine result is not explained by an amphetamine prescription.
Why does a methamphetamine positive also show amphetamine on the same report?
Methamphetamine is partly metabolized into amphetamine in the body, so a urine sample from someone who used methamphetamine will usually confirm positive for both, with methamphetamine at a higher level. This is expected and does not mean two separate drugs were used.
Can a Vicks inhaler really cause a false positive methamphetamine test?
The OTC nasal inhaler formulation containing levmetamfetamine, the l-isomer of methamphetamine, can produce a confirmed methamphetamine result on a standard test because routine GC/MS confirmation does not distinguish isomers by default. An MRO can request d,l-stereoisomer testing to determine whether the result is consistent with the inhaler rather than actual methamphetamine use.
What is the difference between the AMP and mAMP lines on a drug test cup?
AMP screens for amphetamine and related amphetamine-type stimulants. mAMP screens specifically for methamphetamine. They are reported separately because the source and legitimate explanations differ significantly between the two.
What should an employer do if an employee's methamphetamine result comes back positive?
The result should go through Medical Review Officer review before any employment action, the same as any other confirmed positive. The MRO will interview the employee, check for the narrow inhaler exception where applicable, and issue a final verified result.
Related reading
This article is general information about how amphetamine and methamphetamine drug testing works and is not medical, legal, or employment law advice. Employers should apply their own testing policy consistently and route every non-negative result through a qualified Medical Review Officer before taking action.
